Literature DB >> 8675734

Adequacy of bone marrow trephine biopsy specimens in children.

M M Reid1, B Roald.   

Abstract

AIMS: To evaluate success in obtaining adequate bone marrow trephine biopsy cores from children.
METHODS: Sections of trephine biopsy cores submitted by 25 centres from children with neuroblastoma over a five year period were reviewed centrally. In cores containing no tumour adequacy was defined as 0.5 cm of well preserved bone marrow after processing. Occasional smaller cores containing obvious tumour were also considered adequate.
RESULTS: Of 822 biopsy specimens, 139 (17%) were inadequate. In 13 centres submitting at least 20 cores failure rates ranged from 2.6 to 50%. There was no improvement over the five years of the study. There was no practically important correlation between the numbers of cores submitted and success in obtaining adequate specimens. Although a lower rate of inadequate biopsy specimens was found when haematologists rather than paediatricians (13 v 29%) were the predominant operators this should not be overinterpreted, not least because of the potentially confounding association between haematologist operators and larger numbers of biopsy specimens, and because the arbitrary subdivision of centres according to operator specialty was crude. The skill of individual operators could not be assessed.
CONCLUSIONS: Many operators do not obtain adequate bone marrow biopsy specimens from children. Improvement is necessary because this is an invasive investigation, often performed under general anaesthesia. Reporting pathologists are well placed to influence practice by pointing out inadequacies in the specimen and suggesting retraining or even a change in operator. Improvement would almost certainly occur if this investigation was restricted to locally recognised successful operators, whatever their specialty. Most centres should review their practice and devise strategies to improve their ability to obtain adequate cores.

Entities:  

Mesh:

Year:  1996        PMID: 8675734      PMCID: PMC500403          DOI: 10.1136/jcp.49.3.226

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

Review 1.  Bone marrow biopsy: a haematologist's view.

Authors:  M M Reid
Journal:  Acta Paediatr       Date:  1993 Jun-Jul       Impact factor: 2.299

2.  Comparative evaluation of the bone marrow by the volumetric method, particle smears, and biopsies in pediatric disorders.

Authors:  M F Ozkaynak; P Scribano; E Gomperts; P Izadi; R Millin; H Isaacs; L J Ettinger
Journal:  Am J Hematol       Date:  1988-11       Impact factor: 10.047

Review 3.  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Authors:  G M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

4.  Audit of bone marrow trephines.

Authors:  P W Bishop; K McNally; M Harris
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

  4 in total
  10 in total

1.  Bone marrow trephine biopsy in infants. European Neuroblastoma Study Group.

Authors:  M M Reid; B Roald
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

2.  Performing bone marrow aspiration and biopsy in children: Recommended guidelines.

Authors:  Oussama Abla; Jeremy Friedman; John Doyle
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

3.  Central review of bone marrow biopsy specimens from patients with neuroblastoma.

Authors:  M M Reid; B Roald
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

4.  Bone marrow trephine biopsy.

Authors:  B J Bain
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

5.  Deterioration in performance in obtaining bone marrow trephine biopsy cores from children. European Neuroblastoma Study Group.

Authors:  M M Reid; B Roald
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

6.  A Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality.

Authors:  Roger S Riley; Paras Gandhi; Susan E Harley; Paulo Garcia; Justin B Dalton; Alden Chesney
Journal:  J Pathol Inform       Date:  2021-05-25

Review 7.  A pathologist's perspective on bone marrow aspiration and biopsy: I. Performing a bone marrow examination.

Authors:  Roger S Riley; Thomas F Hogan; Dawn R Pavot; Robert Forysthe; Davis Massey; Eileen Smith; Lou Wright; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

8.  Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.

Authors:  Mihai Merzianu; Adrienne Groman; Alan Hutson; Claudiu Cotta; Russell K Brynes; Attilio Orazi; Vishnu Reddy; Julie Teruya-Feldstein; Ramila Amre; Manjula Balasubramanian; Guilherme Brandao; Sindhu Cherian; Elizabeth Courville; David Czuchlewski; Guang Fan; David Grier; Daniela Hoehn; Kedar V Inamdar; Ridas Juskevicius; Prabhjot Kaur; John Lazarchick; Michael R Lewis; Rodney R Miles; Jerome B Myers; Michel R Nasr; Hina N Qureishi; Horatiu Olteanu; Valentin G Robu; Gratian Salaru; Neerja Vajpayee; Jeffrey Vos; Ling Zhang; Shanxiang Zhang; Le Aye; Elisa Brega; James E Coad; John Grantham; Sinisa Ivelja; Robert McKenna; Kieran Sultan; Gregory Wilding; Robert Hutchison; LoAnn Peterson; Richard T Cheney
Journal:  Am J Clin Pathol       Date:  2018-10-01       Impact factor: 2.493

Review 9.  A powered bone marrow biopsy system versus manual methods: a systematic review and meta-analysis of randomised trials.

Authors:  Jeffrey Voigt; Michael Mosier
Journal:  J Clin Pathol       Date:  2013-06-01       Impact factor: 3.411

10.  Bone Marrow Biopsy Operator Experience and Impact on Aspirate, Biopsy, and Ancillary Testing Quality.

Authors:  Lisa M Marinelli; Hong Fang; Matthew T Howard; Curtis A Hanson; Joseph J Haack; Edward A Eick; Richard J Allen; David E Ruffridge; Colleen M Byrne; Rebecca L King
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2018-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.